|
Hydrogen Peroxide-Activated Compounds as Selective Anti-Cancer Therapeutics (115026)
The design of DNA-based agents for cancer treatment has slowed dramatically because of the perception that these agents will have high levels of off-target effects on healthy, non-cancerous cells. Normal off-target effects include modification or interaction of DNA in these non-cancerous, highly replicating cells. This off-target reactivity limits tolerated...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Mark Wunderlich, James Mulloy, Safnas AbdulSalam, Anish Vadukoot, Edward Merino
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Biomedical
|